|
CN101732711A
|
|
Preparation of nose-spraying flu immunization pentavalent or multivalent inactivated vaccine and application thereof
|
|
CN101717787A
|
|
Carrier and application thereof of hepatic tissue specific expression rtTA
|
|
CN101695569A
|
|
Univalent and bivalent gene engineered subunit vaccine for hand-foot-and-mouth disease and preparation method thereof
|
|
CN101692089A
|
|
Immunochromatographic test paper for detecting mycobacterium bovis antibodies and preparation method thereof
|
|
CN101648997A
|
|
IgY antibody for resisting botulinus toxin substrate peptide SubA as well as preparation method and application thereof
|
|
CN101691406A
|
|
New fusion protein SSI, application and special gene thereof
|
|
CN101591387A
|
|
PEG-IFN omega conjugate
|
|
CN1831132A
|
|
Method for expression of Aspergillus flavus urate oxidase and the special gene thereof
|
|
CN1786197A
|
|
Method of detecting bioterror related pathogen bacteria and its special DNA chip
|
|
CN1763184A
|
|
Novel bifunctional molecule of RGD staphylokinase, its preparation process and application
|
|
CN1632581A
|
|
Process for extracting prokaryotic microorganism DNA in sample and special reagent thereof
|
|
CN101788559A
|
|
Immune chromatography test paper strip based on up-conversion luminescence technology
|
|
WO2004096852A1
|
|
A RECOMBINANT HUMAN INTERFERON ϖ, THE METHOD FOR EXPRESSING IT AND THE USES OF IT
|
|
CN1621415A
|
|
Immunoglobulin antibody against SARS-CoV and its preparing method
|
|
CN1621417A
|
|
Antibody against SARS-CoV IgY and its preparing method
|
|
CN1589898A
|
|
Application of human interferon alpha 2a in preparation of medicine for preventing and treating SARS
|
|
CN1566334A
|
|
Novel reovirus, its antibody and vaccine and use thereof
|
|
CN1491955A
|
|
Method for extracting bacteria mRNA
|
